Tilray Brands Inc TLRY

When asked in an interview about German news - Simon

[Keeler]

stated that 'Europe is a big country - with 600 million people'.
That was funny.

I'm going to give everyone the benefit of the doubt - and suggest that most everyone after grade 6 are aware that Eureope is not a country - and in fact, has a population of more like 750 million.

I think whoever the author of the article below is - he is completely uninformed as to Tilray and it's operations.

In my opinion, posting mis-information like this serves no purpose to readers on the Tilray board - I feel it's actually a dis-service. 


"the Middle East and Africa (including Germany)."
Germany is NOT part of Africa - it's located within the 'continent' of Europe

" The largest U.S. company in the U.S. cannabis market, Tilray generates........"
Tilray is NOT the largest U.S. company in the U.S. cannabis market - Tilray DOES not have cannabis operations or sell cannabis in the U.S. whatsoever.
It's a ridiculous statement that even promoters know is not factual. 
Seriously?

45% of its annual revenue ($285 million) from Europe,
No, Tilray does not generate half of its  revenue from international cannabis sales. Again, it's so uninformed that it's laughable. Simple add Tilray's Canadian cannabis ($280 million) and alcohol ($200 million?) and the calculation that their international sales are 45% is absurd.

Post by Ventura2020on Mar 24, 2024 12:43am

174 Views 

Post# 35949255

TLRY Tilray Brands Rallies 13%

over Germany cannabis legalization and US comments

18:27 22 March 2024

Shares of companies related to the medical marijuana market are seeing euphoric gains today. Shares of Tilray (TLRY.US), Canopy Growth (CGC.US), Aurora Cannabis (ACB.US), and Cronos (CRON.US). Earlier this week, Vice President Kamala Harris spoke optimistically about the U.S. administration's efforts to date to reduce federal regulations. Positive news also came from Germany, which intends to loosen regulations, providing cannabis legalization.

• Kamala Harris conveyed that the time has come for the US, 'to legalize marijuana.' This represents only a fraction of the broader background, as the key news for the market came from Germany. The first step in this direction is expected to be the deletion of cannabis from its status as a 'narcotic' to a less dangerous substance, as recommended by the U.S. Department of Health and Human Services, 2023.
• Canopy Growth is trading up nearly 50% today, and has a fairly busy calendar this week, including the prospect of forming a Canopy USA holding company through which it could achieve the rapid legalization of marijuana in America.
• A Marijuana Moment source pointed out that Germany has passed a bill that will likely fully legalize marijuana, after German lawmakers today refused to take a legal step that would have delayed the process by six months.
• As a result, marijuana will become legal in Germany on April 1 - legalizing marijuana possession, home cultivation, and distribution to members of "social clubs." Germany's Health Minister Karl Lauterbach confirmed the reports. The next phase of legalization will come when Germany passes legislation standardizing commercial production and retail sales
• Canopy Growth generates 12% of its revenue from Germany in particular, and is likely to benefit from these changes.  The largest U.S. company in the U.S. cannabis market, Tilray generates about 45% of its annual revenue ($285 million) from Europe, the Middle East and Africa (including Germany). Cronos, on the other hand, is less likely to benefit, becasue according to S&P Global Market Intelligence, about 99% of its revenue comes from just two countries: Canada and Israel.

https://www.xtb.com/en/market-analysis/tilray-rallies-13-over-germany-cannabis-legalization-and-us-comments